Publication Name	World Journal of Gastroenterology
Manuscript ID	18855
Country	France

Received	2015-04-28 15:41
Peer-Review Started	2015-05-05 21:05
To Make the First Decision	2015-08-26 09:51
Return for Revision	2015-09-01 17:20
Revised	2015-09-22 20:29
Second Decision	2015-11-11 16:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-12-01 08:06
Articles in Press	2015-12-01 08:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-12-29 16:28
Publish the Manuscript Online	2016-01-15 14:54

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Ramakrishnan Ayloor Seshadri and Olivier Glehen
Funding Agency and Grant Number
Corresponding Author	Olivier Glehen, Professor, Chief of Service, Service de Chirurgie Viscérale et Endocrinienne, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, 69495 Pierre-Bénite Cedex, France. olivier.glehen@chu-lyon.fr
Key Words	Gastric cancer; Peritoneal carcinomatosis; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy
Core Tip	Peritoneal carcinomatosis (PC) associated with gastric cancer has a poor prognosis. Systemic chemotherapy is not very effective in this situation and therefore, regional therapies like cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) have been investigated to improve the survival of these patients. HIPEC has been used as an adjuvant after curative resection, in the treatment of established PC and in palliating intractable ascites in gastric cancer. This review looks at the current status of HIPEC in peritoneal metastasis due to gastric cancer.
Publish Date	2016-01-15 14:54
Citation	Seshadri RA, Glehen O. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 2016; 22(3): 1114-1130
URL	http://www.wjgnet.com/1007-9327/full/v22/i3/1114.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i3.1114

Full Article (PDF)	WJG-22-1114.pdf
Full Article (Word)	WJG-22-1114.doc
Manuscript File	18855-Review.docx
Answering Reviewers	18855-Answering reviewers.pdf
Audio Core Tip	18855-Audio core tip.mp3
Copyright License Agreement	18855-Copyright assignment.pdf
Peer-review Report	18855-Peer-review(s).pdf
Scientific Misconduct Check	18855-Scientific misconduct check.pdf
Scientific Editor Work List	18855-Scientific editor work list.pdf